GlassScriptPhysician profile
Takintope Akinbiyi
NPI 1497048805
$5,610.21
in general payments reported to CMS, 2019-2025
12 companies · $513 in 2025
The $513 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,645 · 2020: $260 · 2021: $61.31 · 2022: $140 · 2023: $2,503 · 2024: $487 · 2025: $513.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,905 · Travel and Lodging: $1,598.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,905.25 |
| Travel and Lodging | $1,598.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,894.98 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Strattice Reconstructive Tissue Matrix Bps |
| Allergan, INC. | $1,795.80 | 2019-2022 | |
| Medical Device Business Services, INC. | $259.99 | 2020 | |
| Mentor Worldwide LLC | $167.26 | 2022-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Integra Lifesciences Corporation | $161.21 | 2023-2025 | Integra, Omnigraft, Surgimend |
| Motiva USA, LLC | $124.71 | 2025 | |
| Polynovo North America LLC | $78.52 | 2023 | |
| Stryker Corporation | $31.17 | 2024 | 1788 |
| Axogen | $30.13 | 2022 | |
| Acera Surgical, INC. | $25.91 | 2025 | Restrata Wound Matrix |
| Solventum Corporation | $24.94 | 2024 | V.A.C.Ulta, V.A.C. Veraflo, Prevena |
| Medline Industries LP | $15.59 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Takintope Akinbiyi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.